Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
wenglitong
- Development stage
- Unknown
- Lead developer
- Guizhou Liangji Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Wenglitong is a Traditional Chinese Medicine (TCM) product, typically administered as a capsule, indicated for the treatment of lower urinary tract symptoms (LUTS) associated with conditions such as overactive bladder (OAB), chronic prostatitis, and benign prostatic hyperplasia (BPH). Developed and manufactured in China, it is composed of several herbal extracts including *Phellodendron amurense*, *Plantago asiatica*, and *Astragalus membranaceus*. In clinical trials, it has been compared to standard-of-care muscarinic antagonists like tolterodine to evaluate its efficacy in reducing urinary frequency, urgency, and incontinence episodes. Its pharmacological profile is characterized by anti-inflammatory and diuretic properties, aimed at improving bladder function and reducing irritation in the urinary tract.
- Brand names
- Wenglitong
- Other names
- Wenglitong capsule瓮沥通
Beyond the preview
Go deeper on wenglitong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on wenglitong.